|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.42 USD | +0.47% |
|
+5.86% | +7.96% |
| 22/12 | North American Morning Briefing : Precious Metals Hit Record High, Tech Stocks Rebound -2- | DJ |
| 19/12 | Barclays Downgrades AGCO to Underweight From Equal Weight, $116 Price Target | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.86 | 7.19 | 8.43 | 9.9 | 5.09 | |||||
Return on Total Capital | 8.52 | 12.8 | 15.29 | 18.13 | 8.79 | |||||
Return On Equity % | 14.17 | 27.9 | 23.88 | 27.43 | -11.16 | |||||
Return on Common Equity | 14.64 | 28.05 | 24.38 | 27.44 | -10.11 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 22.49 | 23.09 | 23.72 | 26.21 | 24.86 | |||||
SG&A Margin | 11.03 | 9.77 | 9.43 | 10.17 | 12.04 | |||||
EBITDA Margin % | 9.88 | 11.66 | 12.41 | 13.83 | 10.75 | |||||
EBITA Margin % | 7.56 | 9.68 | 10.75 | 12.23 | 8.59 | |||||
EBIT Margin % | 6.91 | 9.13 | 10.28 | 11.83 | 7.9 | |||||
Income From Continuing Operations Margin % | 4.59 | 8.09 | 6.91 | 8.13 | -4.16 | |||||
Net Income Margin % | 4.67 | 8.05 | 7.03 | 8.13 | -3.64 | |||||
Net Avail. For Common Margin % | 4.67 | 8.05 | 7.03 | 8.13 | -3.64 | |||||
Normalized Net Income Margin | 4.28 | 5.71 | 6.1 | 6.15 | 4.17 | |||||
Levered Free Cash Flow Margin | 8.07 | 1.28 | 3.22 | 3.31 | 6.31 | |||||
Unlevered Free Cash Flow Margin | 8.24 | 1.42 | 3.45 | 3.61 | 7.17 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.13 | 1.26 | 1.31 | 1.34 | 1.03 | |||||
Fixed Assets Turnover | 5.58 | 6.77 | 7.5 | 7.48 | 5.71 | |||||
Receivables Turnover (Average Receivables) | 11.05 | 12.06 | 11.43 | 10.2 | 8.12 | |||||
Inventory Turnover (Average Inventory) | 3.5 | 3.75 | 3.34 | 3.21 | 2.84 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.3 | 1.45 | 1.4 | 1.46 | 1.34 | |||||
Quick Ratio | 0.59 | 0.54 | 0.49 | 0.51 | 0.49 | |||||
Operating Cash Flow to Current Liabilities | 0.27 | 0.19 | 0.21 | 0.25 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 33.13 | 30.27 | 31.92 | 35.79 | 45.08 | |||||
Days Outstanding Inventory (Average Inventory) | 104.58 | 97.32 | 109.37 | 113.78 | 128.89 | |||||
Average Days Payable Outstanding | 46.35 | 38.41 | 43.88 | 43.46 | 45.91 | |||||
Cash Conversion Cycle (Average Days) | 91.36 | 89.18 | 97.41 | 106.11 | 128.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 59.6 | 48.54 | 42.1 | 33.88 | 69.92 | |||||
Total Debt / Total Capital | 37.34 | 32.68 | 29.63 | 25.31 | 41.15 | |||||
LT Debt/Equity | 46.14 | 44.51 | 35.94 | 32.58 | 58.52 | |||||
Long-Term Debt / Total Capital | 28.91 | 29.96 | 25.3 | 24.33 | 34.44 | |||||
Total Liabilities / Total Assets | 64.51 | 62.49 | 61.57 | 59.23 | 63.87 | |||||
EBIT / Interest Expense | 25.39 | 40.04 | 28.27 | 24.78 | 5.78 | |||||
EBITDA / Interest Expense | 38.99 | 54.24 | 35.66 | 30.18 | 8.42 | |||||
(EBITDA - Capex) / Interest Expense | 28.15 | 43.62 | 27.22 | 22.65 | 5.95 | |||||
Total Debt / EBITDA | 1.85 | 1.21 | 1 | 0.76 | 2.11 | |||||
Net Debt / EBITDA | 0.7 | 0.57 | 0.52 | 0.47 | 1.65 | |||||
Total Debt / (EBITDA - Capex) | 2.57 | 1.51 | 1.31 | 1.01 | 2.98 | |||||
Net Debt / (EBITDA - Capex) | 0.97 | 0.71 | 0.67 | 0.63 | 2.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.2 | 21.73 | 13.58 | 13.92 | -19.08 | |||||
Gross Profit, 1 Yr. Growth % | 3.69 | 25.02 | 16.68 | 25.86 | -23.25 | |||||
EBITDA, 1 Yr. Growth % | 13.68 | 43.66 | 20.87 | 26.95 | -37.6 | |||||
EBITA, 1 Yr. Growth % | 18.34 | 55.88 | 26.18 | 29.56 | -43.65 | |||||
EBIT, 1 Yr. Growth % | 20.79 | 60.89 | 27.85 | 31.11 | -46.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 241.86 | 114.75 | -2.97 | 33.91 | -141.46 | |||||
Net Income, 1 Yr. Growth % | 241.13 | 110.02 | -0.82 | 31.68 | -136.26 | |||||
Normalized Net Income, 1 Yr. Growth % | 27.04 | 62.33 | 21.35 | 14.91 | -44.98 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 246.63 | 109.73 | 0.17 | 31.68 | -136.43 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.93 | 15.83 | 23.18 | 31.44 | -21.05 | |||||
Inventory, 1 Yr. Growth % | -5.02 | 31.37 | 22.98 | 7.87 | -20.62 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.37 | -3.27 | 8.41 | 19.49 | -5.23 | |||||
Total Assets, 1 Yr. Growth % | 9.59 | 7.97 | 10.04 | 13.04 | -2.02 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.57 | 41.78 | 25.77 | 36.58 | -60.41 | |||||
Common Equity, 1 Yr. Growth % | 4.42 | 14.63 | 13.66 | 19.94 | -19.63 | |||||
Cash From Operations, 1 Yr. Growth % | 28.83 | -26.36 | 26.96 | 31.6 | -37.46 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.28 | -0.04 | 43.92 | 33.43 | -24.09 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 86.07 | -80.69 | 185.93 | 16.93 | 51.17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 81.75 | -78.99 | 175.43 | 19.08 | 57.69 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.59 | 18.75 | 21.05 | 20.65 | 4.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.09 | 10.99 | 17.59 | 13.75 | -3.99 | |||||
Gross Profit, 2 Yr. CAGR % | 1.51 | 13.86 | 20.78 | 21.18 | -1.72 | |||||
EBITDA, 2 Yr. CAGR % | 7.15 | 27.79 | 31.77 | 23.87 | -10.64 | |||||
EBITA, 2 Yr. CAGR % | 10.91 | 35.82 | 40.25 | 27.86 | -14.17 | |||||
EBIT, 2 Yr. CAGR % | 12.72 | 39.41 | 43.42 | 29.47 | -15.83 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 21.64 | 170.95 | 44.35 | 13.99 | -25.49 | |||||
Net Income, 2 Yr. CAGR % | 22.31 | 167.67 | 44.32 | 14.28 | -30.9 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.14 | 43.61 | 36.84 | 18.09 | -20.71 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.63 | 169.63 | 44.94 | 14.85 | -30.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.39 | 11.29 | 19.45 | 27.24 | 1.87 | |||||
Inventory, 2 Yr. CAGR % | 1.71 | 11.7 | 27.1 | 15.18 | -7.46 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.4 | 0.48 | 2.41 | 13.82 | 6.41 | |||||
Total Assets, 2 Yr. CAGR % | 5.6 | 8.78 | 9 | 11.53 | 5.24 | |||||
Tangible Book Value, 2 Yr. CAGR % | 18.71 | 28.01 | 34.16 | 31.51 | -26.47 | |||||
Common Equity, 2 Yr. CAGR % | 0.8 | 9.41 | 14.14 | 16.76 | -1.81 | |||||
Cash From Operations, 2 Yr. CAGR % | 22.66 | -2.6 | -3.31 | 29.26 | -9.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | 15.22 | -0.66 | 19.94 | 38.58 | 0.64 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 25.93 | -40.06 | -25.7 | 82.85 | 34.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 24.17 | -38.2 | -23.92 | 81.1 | 38.34 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.28 | 9.83 | 19.9 | 20.85 | 12.29 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.28 | 6 | 11.85 | 16.35 | 1.54 | |||||
Gross Profit, 3 Yr. CAGR % | 5.24 | 8.81 | 14.79 | 22.45 | 4.07 | |||||
EBITDA, 3 Yr. CAGR % | 9.21 | 18.15 | 25.44 | 30.14 | -1.18 | |||||
EBITA, 3 Yr. CAGR % | 13.63 | 24.24 | 32.53 | 36.59 | -2.4 | |||||
EBIT, 3 Yr. CAGR % | 15.11 | 26.91 | 35.44 | 39.19 | -3.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 30.41 | 47.02 | 92.41 | 40.78 | -18.64 | |||||
Net Income, 3 Yr. CAGR % | 31.83 | 46.46 | 92.25 | 39.98 | -22.05 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.88 | 32.82 | 35.77 | 29.1 | -8.54 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 34.54 | 49.03 | 93.83 | 40.38 | -21.67 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.66 | 4.04 | 15.12 | 23.32 | 8.53 | |||||
Inventory, 3 Yr. CAGR % | 1.77 | 10.76 | 15.34 | 20.34 | 1.74 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.06 | 5.64 | 3.05 | 7.81 | 7.08 | |||||
Total Assets, 3 Yr. CAGR % | 2.18 | 6.38 | 9.2 | 10.33 | 6.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.22 | 25.95 | 27.65 | 35.27 | -11.86 | |||||
Common Equity, 3 Yr. CAGR % | -0.55 | 5.21 | 10.8 | 16.04 | 3.09 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.78 | 3.47 | 6.4 | 7.16 | 1.48 | |||||
Capital Expenditures, 3 Yr. CAGR % | 9.8 | 9.89 | 12.41 | 24.28 | 13.39 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 33.44 | -32.6 | 0.9 | -13.57 | 72.8 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.79 | -31.32 | 1.7 | -11.67 | 74.04 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.55 | 8.2 | 13.45 | 20.15 | 15.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.15 | 8.49 | 8.78 | 9.04 | 5.22 | |||||
Gross Profit, 5 Yr. CAGR % | 5.68 | 11.16 | 11.2 | 13.6 | 7.88 | |||||
EBITDA, 5 Yr. CAGR % | 7.04 | 17.71 | 17.73 | 20.41 | 9.52 | |||||
EBITA, 5 Yr. CAGR % | 10.17 | 25.13 | 23.61 | 25.67 | 11.39 | |||||
EBIT, 5 Yr. CAGR % | 10.52 | 27.64 | 25.7 | 27.93 | 11.97 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.72 | 41.27 | 35.81 | 32.79 | 31.65 | |||||
Net Income, 5 Yr. CAGR % | 9.9 | 41.15 | 36.69 | 32.62 | 27.68 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.55 | 30.94 | 30.22 | 26.72 | 9.55 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 13.05 | 43.32 | 38.61 | 34.28 | 28.43 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.45 | 2.17 | 3.68 | 12.77 | 9.63 | |||||
Inventory, 5 Yr. CAGR % | 6.76 | 11.36 | 11.24 | 12.51 | 5.61 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.44 | 3.53 | 3.39 | 8.84 | 4.39 | |||||
Total Assets, 5 Yr. CAGR % | 5.53 | 5.08 | 4.85 | 8.41 | 7.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.03 | 16.86 | 21.17 | 28.38 | 2.52 | |||||
Common Equity, 5 Yr. CAGR % | 0.98 | 4.24 | 5.09 | 9.69 | 5.57 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.33 | 12.31 | 7.73 | 13.11 | -0.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.01 | 6.06 | 13.75 | 20.57 | 7.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 8.35 | -1.6 | 5.58 | 0.47 | 13.14 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.2 | -4.11 | 4.82 | 1.22 | 15.02 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.92 | 7.89 | 10.44 | 13.09 | 12.99 |
- Stock Market
- Equities
- AGCO Stock
- Financials AGCO Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















